Intrinsic Value of S&P & Nasdaq Contact Us

Edesa Biotech, Inc. EDSA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • CA • USD

SharesGrow Score
66/100
3/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — EDSA

Edesa Biotech, Inc. (EDSA) has a market capitalization of $43.58M and trades at $5.22. The 52-week range is 0.72-9.37.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.1, Earnings Per Share (EPS) of $-1.27.

The stock has a beta of -0.68, operates in the Healthcare sector.

Trading Data
Current Price$5.22
52-Week Range0.72-9.37
Volume418.45K
Avg Volume (30D)4.46M
Market Cap$43.58M
Beta (1Y)-0.68
Company
IPO Date2010-06-21
Employees16
CEOPardeep Nijhawan
CountryCA
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINCA27966L3065
CUSIP27966L108
Income (Latest Year)
Gross Profit$-119.27K
EBITDA$-7.07M
Operating Income$-7.91M
Net Income$-7.19M
EPS$-1.27
EPS Diluted$-1.27
Shares Outstanding$5.68M
Balance Sheet (Latest Year)
Total Assets$13.53M
Current Assets$11.51M
Cash & ST Investments$10.79M
Total Liabilities$1.08M
Net Debt$-10.79M
Total Equity$12.45M
Valuation Ratios
P/E Ratio-4.1
P/B Ratio3.5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message